drugset / Trial / NCT04377152

Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer

NCT04377152 ↗

Expanded access Approved for marketing University of California, San Francisco

Summary

This expanded access protocol provides eligible participants with investigational 68Ga-PSMA-11 PET imaging to detect and localize prostate cancer for initial and subsequent treatment strategy.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Gallium-PSMA-11 Diagnostic / imaging agent — —